PRO-DEX, INC. Selling, General and Administrative Expense
PRO-DEX, INC. (PDEX) reported Selling, General and Administrative Expense of $8.00 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-09-03
- PRO-DEX, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.54M, a 104.91% increase year-over-year.
- PRO-DEX, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.21M, a 82.66% increase year-over-year.
- PRO-DEX, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.75M, a 21.70% increase year-over-year.
- PRO-DEX, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.49M.
- PRO-DEX, INC. selling, general and administrative expense for fiscal 2026 was $8.00M, a 54.27% increase from fiscal 2025.
- PRO-DEX, INC. selling, general and administrative expense for fiscal 2025 was $5.18M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | $4.76M derived: sum of 2 quarters · filed 2026-09-03 | $6.51M derived: sum of 3 quarters · filed 2026-09-03 | $8.00M 10-K · filed 2026-09-03 |
| 2026-03-31 | $2.21M 10-Q · filed 2026-04-30 | $3.96M derived: sum of 2 quarters · filed 2026-04-30 | $5.45M 10-Q · filed 2026-04-30 | $6.70M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-12-31 | $1.75M 10-Q · filed 2026-01-29 | $3.24M 10-Q · filed 2026-01-29 | $4.48M derived: sum of 3 quarters · filed 2026-09-03 | $5.70M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-09-30 | $1.49M derived: 10-K 12 month − 3 quarters · filed 2026-09-03 | $2.73M derived: sum of 2 quarters · filed 2026-09-03 | $3.94M derived: sum of 3 quarters · filed 2026-09-03 | $5.38M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-06-30 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | $2.45M derived: sum of 2 quarters · filed 2026-09-03 | $3.89M derived: sum of 3 quarters · filed 2026-09-03 | $5.18M 10-K · filed 2026-09-03 |
| 2025-03-31 | $1.21M 10-Q · filed 2026-04-30 | $2.65M derived: sum of 2 quarters · filed 2026-04-30 | $3.94M 10-Q · filed 2026-04-30 | |
| 2024-12-31 | $1.44M 10-Q · filed 2026-01-29 | $2.73M 10-Q · filed 2026-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |